From acute intervention to chronic management: Biopharmaceutical barriers and advanced formulation strategies for Peroral metronomic chemotherapy.
Although cancer is a chronic disease, conventional oncology has largely relied on maximum tolerated dose (MTD) chemotherapy to achieve rapid tumor killing. However, the limited specificity of these agents frequently results in substantial systemic toxicity and necessitates prolonged treatment-free intervals that may pe...